Vycor Medical, Inc. (VYCO)
USD 0.07
(24.05%)
USD 0.07
(24.05%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 4.31 Million USD | 13.59% |
| 2022 | 3.8 Million USD | 14.13% |
| 2021 | 3.33 Million USD | 12.22% |
| 2020 | 2.96 Million USD | 21.31% |
| 2019 | 2.44 Million USD | 34.97% |
| 2018 | 1.81 Million USD | 32.5% |
| 2017 | 1.36 Million USD | -9.5% |
| 2016 | 1.51 Million USD | 72.37% |
| 2015 | 877 Thousand USD | -5.17% |
| 2014 | 924.84 Thousand USD | -82.97% |
| 2013 | 5.43 Million USD | 35.13% |
| 2012 | 4.01 Million USD | 49.05% |
| 2011 | 2.69 Million USD | 34.22% |
| 2010 | 2 Million USD | 32.78% |
| 2009 | 1.51 Million USD | -2.7% |
| 2008 | 1.55 Million USD | 142.6% |
| 2007 | 640.9 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 4.48 Million USD | 3.92% |
| 2024 Q2 | 4.52 Million USD | 0.85% |
| 2023 Q2 | 3.92 Million USD | -0.19% |
| 2023 FY | 4.31 Million USD | 13.59% |
| 2023 Q4 | 4.31 Million USD | 0.72% |
| 2023 Q3 | 4.28 Million USD | 9.25% |
| 2023 Q1 | 3.93 Million USD | 3.43% |
| 2022 Q1 | 3.51 Million USD | 5.67% |
| 2022 FY | 3.8 Million USD | 14.13% |
| 2022 Q3 | 3.76 Million USD | 7.4% |
| 2022 Q4 | 3.8 Million USD | 0.84% |
| 2022 Q2 | 3.5 Million USD | -0.28% |
| 2021 Q3 | 3.29 Million USD | 1.75% |
| 2021 Q2 | 3.24 Million USD | 0.35% |
| 2021 FY | 3.33 Million USD | 12.22% |
| 2021 Q1 | 3.23 Million USD | 8.9% |
| 2021 Q4 | 3.33 Million USD | 0.93% |
| 2020 Q1 | 2.69 Million USD | 10.01% |
| 2020 Q3 | 2.93 Million USD | 9.4% |
| 2020 FY | 2.96 Million USD | 21.31% |
| 2020 Q4 | 2.96 Million USD | 1.06% |
| 2020 Q2 | 2.68 Million USD | -0.25% |
| 2019 Q3 | 2.35 Million USD | 9.05% |
| 2019 FY | 2.44 Million USD | 34.97% |
| 2019 Q1 | 2.16 Million USD | 19.64% |
| 2019 Q2 | 2.15 Million USD | -0.51% |
| 2019 Q4 | 2.44 Million USD | 3.98% |
| 2018 FY | 1.81 Million USD | 32.5% |
| 2018 Q2 | 1.5 Million USD | -8.5% |
| 2018 Q4 | 1.81 Million USD | -0.93% |
| 2018 Q3 | 1.82 Million USD | 21.2% |
| 2018 Q1 | 1.64 Million USD | 20.61% |
| 2017 Q4 | 1.36 Million USD | 3.0% |
| 2017 FY | 1.36 Million USD | -9.5% |
| 2017 Q1 | 1.32 Million USD | -12.05% |
| 2017 Q2 | 969.39 Thousand USD | -27.09% |
| 2017 Q3 | 1.32 Million USD | 37.01% |
| 2016 FY | 1.51 Million USD | 72.37% |
| 2016 Q1 | 890.96 Thousand USD | 1.59% |
| 2016 Q4 | 1.51 Million USD | 32.2% |
| 2016 Q3 | 1.14 Million USD | 11.62% |
| 2016 Q2 | 1.02 Million USD | 14.98% |
| 2015 Q2 | 791.59 Thousand USD | -10.1% |
| 2015 FY | 877 Thousand USD | -5.17% |
| 2015 Q4 | 877 Thousand USD | 1.15% |
| 2015 Q3 | 867.04 Thousand USD | 9.53% |
| 2015 Q1 | 880.55 Thousand USD | -4.79% |
| 2014 Q2 | 3.3 Million USD | -35.29% |
| 2014 Q1 | 5.1 Million USD | -5.93% |
| 2014 FY | 924.84 Thousand USD | -82.97% |
| 2014 Q4 | 924.84 Thousand USD | -9.75% |
| 2014 Q3 | 1.02 Million USD | -69.0% |
| 2013 Q3 | 5.08 Million USD | 10.36% |
| 2013 Q2 | 4.6 Million USD | 4.73% |
| 2013 Q1 | 4.4 Million USD | 9.49% |
| 2013 FY | 5.43 Million USD | 35.13% |
| 2013 Q4 | 5.43 Million USD | 6.78% |
| 2012 Q3 | 3.86 Million USD | 21.9% |
| 2012 Q4 | 4.01 Million USD | 3.96% |
| 2012 Q1 | 3.03 Million USD | 12.38% |
| 2012 Q2 | 3.17 Million USD | 4.65% |
| 2012 FY | 4.01 Million USD | 49.05% |
| 2011 Q1 | 2.67 Million USD | 33.03% |
| 2011 Q2 | 2.81 Million USD | 5.4% |
| 2011 FY | 2.69 Million USD | 34.22% |
| 2011 Q3 | 2.66 Million USD | -5.54% |
| 2011 Q4 | 2.69 Million USD | 1.33% |
| 2010 FY | 2 Million USD | 32.78% |
| 2010 Q3 | 756.34 Thousand USD | 16.31% |
| 2010 Q2 | 650.26 Thousand USD | -31.98% |
| 2010 Q1 | 956 Thousand USD | -36.81% |
| 2010 Q4 | 2 Million USD | 165.6% |
| 2009 FY | 1.51 Million USD | -2.7% |
| 2009 Q4 | 1.51 Million USD | -23.62% |
| 2009 Q3 | 1.98 Million USD | 8.84% |
| 2009 Q2 | 1.81 Million USD | 10.87% |
| 2009 Q1 | 1.64 Million USD | 5.57% |
| 2008 FY | 1.55 Million USD | 142.6% |
| 2008 Q4 | 1.55 Million USD | 0.0% |
| 2007 FY | 640.9 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 16.62 Million USD | 74.025% |
| IR-Med Inc. | 634 Thousand USD | -581.037% |
| Polarean Imaging plc | 2.58 Million USD | -67.321% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -537.201% |
| Avitar, Inc. | 11.59 Million USD | 62.757% |
| AVITA Medical, Inc. | 19.86 Million USD | 78.265% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -103.861% |
| Össur hf. | 688.8 Million USD | 99.373% |
| Zecotek Photonics Inc. | 5.86 Million USD | 26.426% |
| QHSLab, Inc. | 2.05 Million USD | -109.901% |
| Wellstar International, Inc. | 55.99 Million USD | 92.288% |
| Össur hf. | 688.8 Million USD | 99.373% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 73.149% |
| Escalon Medical Corp. | 2.94 Million USD | -46.447% |
| Aurora Spine Corporation | 6.65 Million USD | 35.106% |
| BrainsWay Ltd. | 15.31 Million USD | 71.805% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | 28.188% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 90.581% |
| Vivos Inc. | 245 Thousand USD | -1662.328% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.826% |
| Kelyniam Global, Inc. | 1.01 Million USD | -326.264% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -1466.602% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -76.249% |
| Nanomix Corporation | 14.81 Million USD | 70.855% |
| Theraclion SA | 13.01 Million EUR | 66.829% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | 15.738% |
| Positron Corporation | 2.02 Million USD | -113.118% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -19.237% |
| Lombard Medical, Inc. | 53.79 Million USD | 91.974% |
| ALR Technologies Inc. | 24.5 Million USD | 82.38% |
| Stratec SE | 271.97 Million USD | 98.412% |
| Heart Tronics, Inc. | 1.09 Million USD | -294.393% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -83.051% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 21.159% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 93.417% |
| VMS Rehab Systems, Inc. | 201.36 USD | -2144205.721% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 21.137% |
| Ingen Technologies, Inc. | 5.7 Million USD | 24.376% |
| Odyssey Group International, Inc. | 6.61 Million USD | 34.695% |
| United American Healthcare Corporation | 119 Thousand USD | -3528.382% |
| ECGI Holdings, Inc. | 11.94 Million USD | 63.839% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -226.12% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -198.532% |
| Urologix, Inc. | 12.64 Million USD | 65.851% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 19.983% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 49.098% |
| SS Innovations International, Inc. | 11.18 Million USD | 61.383% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -721.827% |
| Smith & Nephew plc | 4.76 Billion USD | 99.909% |
| NIOX Group Plc | 9.8 Million USD | 55.951% |
| Fuse Medical, Inc. | 15.11 Million USD | 71.425% |
| Broncus Holding Corporation | 10.43 Million USD | 58.611% |
| Brain Scientific Inc. | 7.42 Million USD | 41.859% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 87.227% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -443.745% |